AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger
AstraZeneca in talks to merge with Bristol Myers Squibb, creating $400B pharma giant, while talks ongoing for months, antitrust scrutiny is expected.
Two big medicine companies are talking about joining together to become one super-large company. When big companies merge, people watch carefully to make sure it's fair for customers and everyone else involved.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.